You are using an older browser version. Please use a supported version for the best MSN experience.

Flush with cash, Pfizer buys Global Blood Therapeutics in $5.4 billion deal

Pfizer is boosting its pipeline with a $5.4 billion deal for blood disorder drugmaker Global Blood Therapeutics, the latest in a series of acquisitions to combat a potential slowdown in COVID-19 products demand as cases fall. Francis Maguire reports.
image beaconimage beaconimage beacon